Maravai LifeSciences Holdings, Inc. (MRVI)
Nasdaq: MRVI · Pharmaceutical Preparations · San Diego, CA · filing with the SEC since 2020
Grade3.8
◀ Past 3.9● Present 4.4▶ Future 2.9
Who owns Maravai LifeSciences Holdings, Inc.
As filed with the SECHolders of 5% or more
2
Blackrock, Inc. holds 5.9% of Common Stock, as its SCHEDULE 13G/A filed Oct 17, 2025 says.
Directors and officers
11
report now, of 33 people on the record since 2020. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 2 named at left.
Holders of 5% or moreshare of the class, as filed
Blackrock, Inc.
SCHEDULE 13G/A · filed Oct 17, 2025 · Common Stock
Millennium Management LLC
SCHEDULE 13G · filed Sep 29, 2026 · Class A Common Stock, par value $0.01 per share · 4.7% in Jun 29, 2026
The Vanguard Group
SCHEDULE 13G/A · filed Oct 31, 2025 · Common Stock · reported falling below 5%, from 6.51% in Jul 29, 2025
12 West Capital Management LP
SCHEDULE 13G/A · filed May 15, 2026 · Class A Common Stock, par value $0.01 per share · reported falling below 5%, from 6.2% in Feb 17, 2026
Stuart Feldman
SCHEDULE 13G/A · filed Aug 13, 2026 · Class A Common Stock, par value $0.01 per share · reported falling below 5%, from 7.06% in May 14, 2026
What MRVI reports owning in othersstakes of 5% or more, and other ties
Other ties the annual report names
Molecular Assemblies, Inc
A company bought · acquisition · Mar 2025 · owns, named in the 10-K filed Feb 26, 2026
Officinae Bio
A company bought · acquisition · Mar 2025 · owns, named in the 10-K filed Feb 26, 2026
Alphazyme, LLC
A company bought · acquisition · owns, named in the 10-K filed Feb 26, 2026
11 subsidiaries in 3 countries, from the list filed with the 10-K filed Feb 26, 2026.
Insider tradesForm 4
2sales
3purchases
2sales on a scheduled plan
1people selling
$300,000sold, in dollars
$1.1Mbought, in dollars
Open-market trades on Form 4 from Nov 12, 2025 to Nov 12, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Nov 12, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window3 of 33 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Oreshack Kurt | General Counsel | 2 | $300,000 | 2 | 0 | $0 |
| Brust Bernd | Chief Executive Officer | 0 | $0 | 0 | 2 | $1.0M |
| Lucier Gregory T | director | 0 | $0 | 0 | 2 | $400,000 |